EcoDrugPlus

Presenilin 1

Ensembl ID : ENSBMSG00010005948
Gene Symbol: PSEN1
1 Cross references
202 Possible Orthologues:

Presenilin 2

Ensembl ID : ENSBMSG00010002147
Gene Symbol: PSEN2
1 Cross references
206 Possible Orthologues:

Presenilin Enhancer, Gamma-Secretase Subunit

Ensembl ID : ENSBMSG00010022076
Gene Symbol: PSENEN
1 Cross references
185 Possible Orthologues:

Progesterone Receptor

Ensembl ID : ENSBMSG00010007436
Gene Symbol: PGR
1 Cross references
194 Possible Orthologues:

Prostaglandin D2 Receptor

Ensembl ID : ENSBMSG00010005665
Gene Symbol: PTGDR
1 Cross references
118 Possible Orthologues:

Prostaglandin E Receptor 1

Ensembl ID : ENSBMSG00010011682
Gene Symbol: PTGER1
1 Cross references
237 Possible Orthologues:

Prostaglandin E Receptor 2

Ensembl ID : ENSBMSG00010005087
Gene Symbol: PTGER2
1 Cross references
244 Possible Orthologues:

Prostaglandin E Receptor 3

Ensembl ID : ENSBMSG00010004995
Gene Symbol: PTGER3
1 Cross references
196 Possible Orthologues:

Prostaglandin E Receptor 4

Ensembl ID : ENSBMSG00010001942
Gene Symbol: PTGER4
1 Cross references
275 Possible Orthologues:

Prostaglandin F Receptor

Ensembl ID : ENSBMSG00010009240
Gene Symbol: PTGFR
1 Cross references
195 Possible Orthologues:

Prostaglandin I2 Receptor

Ensembl ID : ENSBMSG00010020919
Gene Symbol: PTGIR
1 Cross references
188 Possible Orthologues:

Prostaglandin-Endoperoxide Synthase 1

Ensembl ID : ENSBMSG00010001760
Gene Symbol: PTGS1
1 Cross references
256 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).